Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
RAD Biomed is an Israel-based private incubator that invests in early-stage biomedical and Hi-Tech start-ups. RAD Biomed invests in exciting new solutions at the earliest stages, providing a full set of operational and professional services, mentorship and industry connections. Rad Biomed was launched by the RAD Group, a group of independent companies that develop, manufacture, and market solutions for diverse segments of the networking and telecommunications industry. The RAD Group has decades of experience in guiding and nurturing start-ups as they grow towards commercial launch, sales growth, and successful exit, with nine Nasdaq IPOs and 10 M&As.
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is RAD BioMed's primary investment focus?
- RAD BioMed is an Israel-based private incubator that invests in early-stage biomedical and Hi-Tech start-ups, with a strong concentration in Health Tech & Life Sciences.
- When was RAD BioMed founded?
- RAD BioMed was founded in 2011.
- Can you name some notable exits for RAD BioMed's portfolio companies?
- Notable exits include Vectorious Medical Technologies, acquired by Edwards Lifesciences for $497 million in September 2025, and BELKIN Vision, acquired by Alcon Pharmaceuticals for $81 million in July 2024. For a full list, please refer to startupim data.
- What is RAD BioMed's investment stage preference?
- RAD BioMed primarily invests in Seed and A Round stages, with some follow-on investments in B Round and Convertible Debt.
- What is the typical investment amount for RAD BioMed?
- RAD BioMed's investment range is typically between $500K and $2M, though individual investments can be higher, such as $12 million in Perflow Medical in 2018.
- How many founders does RAD BioMed have?
- RAD BioMed has two founders: Yehuda Zisapel and Nava Zisapel.
- What is the operational background of RAD BioMed?
- RAD BioMed was launched by the RAD Group, which has extensive experience in guiding and nurturing start-ups, including nine Nasdaq IPOs and 10 M&As.
- Has RAD BioMed had any recent investments?
- Yes, RAD BioMed invested $9 million in FEMSelect in October 2022 and $4 million in CVAid Medical in February 2022.